A sweet tool in the control of Deafness: A therapeutic mix encompassing D-Allulose/D-Psicose, Cholecalciferol, Ajoene and DIM (ACAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 16/April/2018, 6.59 am

Treating pain with Endorphins: Endorphin-based activation of the PD-1 pathway for Pain therapy: β-Endorphin, an endogenous opioid neuropeptide and peptide hormone known to play a role in hunger, thrill, pain, maternal care, reward, and cognition, increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 14/April/2018, 11.47 pm
April 14, 2018
An oxytocin-way to say no to cardiac diseases: Oxytocin-based inhalation therapy for attenuating pathogenesis-associated with Myocardial infarction: Inhalation of oxytocin decreases IRF3 (Interferon regulatory transcription factor-3), GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 16/April/2018, 8.05 am
April 16, 2018
Show all

 

What we say:

Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:   Combinatorial therapy for Deafness: A therapeutic mix encompassing D-Allulose/D-Psicose, Cholecalciferol, Ajoene and DIM (ACAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes


From Significance of the study to Public health relevance:

Given that: (1) more than one seventh of the global population suffers from hearing impairment;  (2) majority of hearing impairment occurs in  low and middle income countries, for instance, 3 in 1000 from developed countries, while 6 in 1000 from developing countries suffer from hearing impairment; (3) damage to the auditory hair cells (HCs) is the principal reason for hearing loss;  (4) only in 50% cases hearing impairment can be cured; and (5) the global annual economic cost spent for unaddressed hearing loss is estimated to be in the range of $750–790 billions, there is an urgent need to find: (i) a way to promote regeneration, growth and proliferation of auditory hair cells  in mammalian cochlea; (ii) a cheaper alternative to the existing expensive drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, hearing impairment.


From research findings to Therapeutic opportunity: 

This study provides, for the first time, mechanistic insights into how a pharmaceutical mixture encompassing  D-Allulose/D-Psicose (a non-caloric sugar/sweetener), Cholecalciferol, Ajoene and DIM (ACAD) may aid in the treatment of hearing impairment.

ACAD, by increasing the expression of its target genes, it may increase the expression of ATG5 (Autophagy-related protein 5). Thereby, it may: (1) prevent degeneration of adult hair cells; (2) prevent aggregation of polyubiquitinated proteins and p62/SQSTM1 in inclusion bodies; (3) promote maintenance of hair cells morphology and hearing acuity; and (4) prevent hearing loss. Thus, pharmacological mixture encompassing ” D-Allulose/D-Psicose, Cholecalciferol, Ajoene and DIM (ACAD) or their analogues, either alone or in combination with other drugs, may be used to treat deafness (Fig.1).

Figure 1 Mechanistic insights into how a therapeutic mix encompassing D-Allulose/D-Psicose, Cholecalciferol, Ajoene and DIM (ACAD) aids in improving hearing impairment. ACAD prevents aggregation of proteins, promotes regeneration of adult hair cells and inhibits hearing impairment via up-regulation of its target gene ATG5

Figure 2. The chemical structure of D-Allulose/D-Psicose. D-Allulose protects against hearing loss through induction of ATG5.


Details of the research findings:

Idea Proposed/Formulated (with experimental evidence) by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does a therapeutic mix encompassing D-Allulose/D-Psicose, Cholecalciferol, Ajoene and DIM (SCAD) increase the expression of ATG5?

Amount: $500#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References:

Web: http://genomediscovery.org or http://newbioideas.com/

Citation: Boominathan, L., A sweet tool in the control of Deafness: A therapeutic mix encompassing D-Allulose/D-Psicose, Cholecalciferol, Ajoene and DIM (ACAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  improves hearing loss via up regulation of its target genes, 16/April/2018, 6.59 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite, drop us a line at admin@genomediscovery.org

Comments are closed.